Clinical case of immunoglobulin G application with сhemo-resistant tuberculosis in combination with HIV-infection with severe immunosuppression
Journal Title: Туберкульоз, легеневі хвороби, ВІЛ-інфекція - Year 2019, Vol 0, Issue 1
Abstract
Chemo-resistant tuberculosis in combination with HIV infection is one of the most difficult problems of modern phthisiology. Of particular interest is the contingent of patients with MDR TB/HIV with a level of CD 4 in blood plasma below 50 cells/µl, indicating the progression of HIV, and the development of severe immunosuppression in the patient’s body. Such patients are more likely to have severe, generalized forms with multiple organ lesions, extra-pulmonary localizations tuberculosis (TB). We represent a clinical case of a patient V., 27 years old. Clinical diagnosis: В-20 HIV-infection IV clinical stage. A19.0 MDR TB (24.07.2015), both lungs (disseminated) desctuction + (infiltrative phase) tuberculosis of the intrathoracic and intraabdominal lymph nodes, intestinal tuberculosis; mbt + mg + rif + m + c + resist 1 + (HRES) resist 2 + (Et) hist 0 cat 4 (new case) coh 2 (2015). Complications: respiratory failure, type 1. Secondary anemia, severe course. Cachexia. Severe immunosuppression. Polyorganic insufficiency. Concomitant diseases: еxfoliative dermatitis. Thrombocytopenic purpura. Oropharyngeal candidiasis. Primary hypothyroidism, moderate, decompensation. Toxic Hepatitis. Stage 2 of chronic renal disease. Encephalopathy. Neuroretinitis of the viral genesis (CMV, Toxo, Rub). Genital herpes. Amenorrhea. The patient received with the standard treatment the intravenous immunoglobulin G, as a pathogenic effect, at a rate of 4 ml/kg intravenously in two steps. It was introduced slowly (30 drops/ minute) and after 5 pm. Conclusions. As a result of the use of the intravenous immunoglobulin (Ig G) in combination with the standard regimens of second-line anti-TB drugs and antiretroviral therapy, improved clinical features and laboratory data and reduced manifestations of the immune reconstitution inflammatory syndrome.
Authors and Affiliations
N. А. Matsegora, A. V. Kaprosh
Keywords
Related Articles
- EP ID EP606971
- DOI 10.30978/TB2019-1-46
- Views 85
- Downloads 0
First results of the introduction of bedaguiline for patients with multidrug resistens tuberculosis in Ukraine: recommendations for practical doctor resume
Objective — to implement approaches for the proper use of new and reprogrammed drugs for the treatment of drug-resistant tuberculosis. Materials and methods. Such an implementation took place within the pilot project Ch...
Estradiol level in patients with pulmonary tuberculosis
Objective — to study the hormonal state of patients with pulmonary tuberculosis by the example of estradiol with its various forms and try to establish a possible relationship between the pathogenesis of tuberculosis and...
The state of the proteolytic system in patients with pulmonary tuberculosis
Based on literature data, the authors outlined the state of the problem of tuberculosis in Ukraine. The urgency of the problem in their opinion is the late timing of the diagnosis of pulmonary tuberculosis and the comple...
Palliative care for co-infection with tuberculosis/HIV. Part 2
-
Effect of antituberculosis treatment on dynamics of carbohydrate and lipid profile
Objective — study the effect of antituberculosis treatment on the dynamics of carbohydrate and lipid profile in patients with newly diagnosed pulmonary tuberculosis Materials and methods. We examined 76 patients with dr...